Preclinical Imaging Laboratory | NYU Langone Health

Skip to Main Content
Scientific Cores & Shared Resources Preclinical Imaging Laboratory

Preclinical Imaging Laboratory

NYU Langone’s Preclinical Imaging Laboratory (RRID:SCR_017937) provides investigators with access to state-of-the-art imaging technologies and strategies to image live animals on the organ, tissue, cell, or molecular level. Our technologies are indispensable to researchers studying and monitoring disease in small living subjects. Learn more about the capabilities of the Preclinical Imaging Laboratory.

To reserve time on an instrument, faculty, staff, and investigators must be registered in iLab. We have also provided iLab login instructions for NYU Langone, NYU, NYU College of Dentistry, and external users.

Requests and Reservations

Request services or reserve instruments using our iLab platform.

Built in partnership with the Department of Radiology, our newly renovated, 4,000-square-foot facility opened in May 2016 and enables researchers to perform noninvasive and nonlethal three-dimensional imaging. The lab is equipped with powerful instruments for micromagnetic resonance imaging, micropositron emission tomography, X-ray microcomputed tomography, bioluminescence and fluorescence scanning, and high-frequency ultrasound.

Our instruments are located conveniently throughout NYU Langone’s facilities on First Avenue in Manhattan. Trained researchers can use them upon approval and for a fee. Devices are located either within or outside the pathogenic barrier and near the various vivaria, providing expanded access and support to investigators conducting diverse biomedical research projects.

We welcome investigators conducting short-term evaluations of animal models or efficient longitudinal studies.

The lab is directed by Youssef Zaim Wadghiri, PhD, associate professor, Department of Radiology, and has three full-time staff.

Contact Us

The Preclinical Imaging Laboratory is located at 550 First Avenue in Medical Science Building 476. For more information, you can reach us at 646-501-0190 or

To contact Dr. Wadghiri, call 212-263-3336 or email

How to Acknowledge the Preclinical Imaging Laboratory

Please use the RRID in all of your citations when using the core.

Detailed descriptions of experimental materials and methods for publications and grants provide transparent reporting. If you’ve used instruments, services, expertise, or data provided by NYU Langone’s Preclinical Imaging Laboratory (RRID:SCR_017937) that is published, presented, or used in a grant application, media release, or any other form of media, we appreciate being acknowledged. Proper acknowledgement enables us to demonstrate our involvement in the research of many laboratories and institutions and helps with future funding.

As a courtesy and for copyright purposes, we also request that you inform us of the publication of any images that were created by the Preclinical Imaging Laboratory.

The Preclinical Imaging Laboratory is partially supported by the Laura and Isaac Perlmutter Cancer Center Support Grant 5P30CA016087 and Center for Advanced Imaging Innovation and Research and National Institute of Biomedical Imaging and Bioengineering (NBIB) Support Grant P41 EB017183. Please acknowledge these grants in all publications resulting from your use of this lab.

The suggested acknowledgement should be worded this way: “This work was supported, in part, by [insert your other funding sources here] and was also performed at the Preclinical Imaging Laboratory, a shared resource partially supported by the Laura and Isaac Perlmutter Cancer Center Support Grant NIH/NCI 5P30CA016087 and NIBIB Biomedical Technology Resource Center Grant NIH P41 EB017183.”

If space is limited, please acknowledge that your work is partially funded by the following grants: NIH/NCI 5P30CA016087 and NIH P41 EB017183.

Authorship should be considered when scientists from the Preclinical Imaging Laboratory make intellectual contributions involving experimental design, advanced analysis, or scientific interpretation. Please sign the Acknowledgment Letter, indicating that you have read and agree to this policy, and return it to Dr. Wadghiri at